122 related articles for article (PubMed ID: 1996540)
1. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
Pacini F; Basolo F; Elisei R; Fugazzola L; Cola A; Pinchera A
Am J Clin Pathol; 1991 Mar; 95(3):300-8. PubMed ID: 1996540
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.
Pacini F; Elisei R; Anelli S; Basolo F; Cola A; Pinchera A
Cancer; 1989 Mar; 63(6):1189-95. PubMed ID: 2563668
[TBL] [Abstract][Full Text] [Related]
3. Expression of calcitonin gene-related peptide in medullary thyroid cancer.
Pacini F; Fugazzola L; Basolo F; Elisei R; Pinchera A
J Endocrinol Invest; 1992; 15(7):539-42. PubMed ID: 1447491
[TBL] [Abstract][Full Text] [Related]
4. Serum tissue polypeptide antigen (TPA) in thyroid cancer.
Martino E; Bambini G; Aghini-Lombardi F; Motz E; Pacini F; Lari R; Baschieri L; Pinchera A
J Endocrinol Invest; 1984 Jun; 7(3):249-52. PubMed ID: 6547969
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Lloyd RV; Sisson JC; Marangos PJ
Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
[TBL] [Abstract][Full Text] [Related]
6. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma.
Rougier P; Calmettes C; Laplanche A; Travagli JP; Lefevre M; Parmentier C; Milhaud G; Tubiana M
Cancer; 1983 Mar; 51(5):855-62. PubMed ID: 6821852
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
[TBL] [Abstract][Full Text] [Related]
8. C cell carcinoma of the thyroid. Follicular variant.
Lertprasertsuke N; Kakudo K; Nakamura A; Tada N; Osamura Y; Watanabe K; Kubota M
Acta Pathol Jpn; 1989 Jun; 39(6):393-9. PubMed ID: 2481937
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.
Dottorini ME; Assi A; Sironi M; Sangalli G; Spreafico G; Colombo L
Cancer; 1996 Apr; 77(8):1556-65. PubMed ID: 8608543
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid.
Kakudo K; Takami H; Katayama S; Matsuura N; Kamoshida S; Miyauchi A; Watanabe K
Acta Pathol Jpn; 1990 Apr; 40(4):261-6. PubMed ID: 2371832
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content.
Schröder S; Böcker W; Baisch H; Bürk CG; Arps H; Meiners I; Kastendieck H; Heitz PU; Klöppel G
Cancer; 1988 Feb; 61(4):806-16. PubMed ID: 2448025
[TBL] [Abstract][Full Text] [Related]
13. Thyroid carcinoma with biphasic clinical course and evolution in medullary carcinoma-follicular variant. A case report and an immunocytochemical demonstration of calcitonin and thyroglobulin in the same neoplastic cells.
Baschieri I; Ronga G; Fiorentino A; Mariani P; Carlei F
J Nucl Med Allied Sci; 1990; 34(2):71-6. PubMed ID: 2246675
[TBL] [Abstract][Full Text] [Related]
14. Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma.
Noel M; Delehaye MC; Segond N; Lasmoles F; Caillou B; Gardet P; Fragu P; Moukhtar MS
Thyroid; 1991; 1(3):249-56. PubMed ID: 1824340
[TBL] [Abstract][Full Text] [Related]
15. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.
Schifter S; Williams ED; Craig RK; Hansen HH
Clin Endocrinol (Oxf); 1986 Dec; 25(6):703-10. PubMed ID: 3308183
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
[TBL] [Abstract][Full Text] [Related]
20. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Kauhanen S; Schalin-Jäntti C; Seppänen M; Kajander S; Virtanen S; Schildt J; Lisinen I; Ahonen A; Heiskanen I; Väisänen M; Arola J; Korsoff P; Ebeling T; Sane T; Minn H; Välimäki MJ; Nuutila P
J Nucl Med; 2011 Dec; 52(12):1855-63. PubMed ID: 22052128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
